Rifampicin-ofloxacin oral regimen for the treatment of mild to moderate diabetic foot osteomyelitis.

J Antimicrob Chemother

Service des Maladies Infectieuses et Tropicales, Hôpital Dron, 135 rue du Pr Coty, F-59200 Tourcoing, France.

Published: December 2001

Seventeen diabetic patients with moderate to mild foot lesions associated with 20 osteomyelitic bones diagnosed by both bone scan and bone biopsy received rifampicin plus ofloxacin for a median duration of 6 months. Cure was defined as disappearance of all signs and symptoms of infection at the end of the treatment and absence of relapse during follow up. At the end of the treatment period, cure was achieved in 15 patients (88.2%) and was maintained in 13 patients (76.5%) at the end of an average post-treatment follow-up of 22 months. No serious drug-related adverse events were recorded.

Download full-text PDF

Source
http://dx.doi.org/10.1093/jac/48.6.927DOI Listing

Publication Analysis

Top Keywords

rifampicin-ofloxacin oral
4
oral regimen
4
regimen treatment
4
treatment mild
4
mild moderate
4
moderate diabetic
4
diabetic foot
4
foot osteomyelitis
4
osteomyelitis seventeen
4
seventeen diabetic
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!